Rejected at 11:05 p.m. Mar, 02, 2024 ] by Cameron
Author: gie001
Related Note: 1488847719405
Rationale for change

The pseudoallergy is now known as Aspirin-exacerbated respiratory disease (AERD) per AMBOSS

Rejection reason

Need link to source, please review suggestion guidelines

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step2_v12::#AMBOSS::n707mh #AK_Step1_v12::#B&B::20_Pulm::02_Obstructive_and_Restrictive_Diseases::02_COPD::Extra #AK_Step1_v12::#B&B::20_Pulm::02_Obstructive_and_Restrictive_Diseases::03_Asthma_and_Bronchiectasis_::Extra #AK_Step2_v12::Original_decks::Dorian::im::uw::pulm_cc #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Pixorize::03_Pharmacology::13_Musculoskeletal_Pharm::05_NSAIDs #AK_Step2_v12::#SketchyIM::03_Pulmonology::02_Obstructive_Pulmonary_Diseases::01_Chronic_Asthma_SOA #PANCE::CARDIO::vascular_disease #AK_Other::AnKing_Image::!Subjects::Biochemistry::Arachidonic_Acid_Pathway #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::04_Aspirin_And_Celecoxib #AK_Step1_v12::#UWorld::Step::1828 #AK_Step1_v12::#NinjaNerd::15_Respiratory::03_Pathology::09_Asthma #AK_Step1_v12::#NBME::29 #PANCE::EOR::Family_med #AK_Other::AnKing_Image::Aiman::Arachidonic_Acid_Pathway #AK_Step2_v12::#UWorld::Step::2842 #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::Pulm_&_Critical_Care #AK_Step1_v12::#Pixorize::03_Pharmacology::13_Musculoskeletal_Pharm::01_Aspirin #PANCE::EOR::IM #AK_Step2_v12::#Resources_by_rotation::IM::uw::pulm_critical_care::pulm_critical_care_zanki #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::06_Antiplatelets::*Aspirin #AK_Step2_v12::#B&B::14_Pulmonary_Critical_Care::01_Pulmonary_Disease::02_Asthma::Extra #AK_Step2_v12::#UWorld::Step::4065 #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::03_Aspirin #AK_Step1_v12::#NBME::Free120 #AK_Step2_v12::#UWorld::COMLEX::100855 #AK_Step2_v12::#UWorld::COMLEX::28653 #AK_Step1_v12::#NBME::22 #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::03_Antiplatelet_agents #AK_Step1_v12::#Physeo::09_Pharm::09_Musculoskeletal::02_Aspirin #AK_Step1_v12::#NBME::21 #AK_Step1_v12::#Bootcamp::Pulmonology::05_Obstructive_Lung_Disease::02_Asthma #AK_Step1_v12::#UWorld::COMLEX::24937 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::03_NSAIDs #AK_Step2_v12::#Resources_by_rotation::IM::uw::pulm_critical_care::pulm_critical_care_dorian #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#AMBOSS::anaQ7O #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step2_v12::#FirstAid::14_Pulm::01_Obstructive_Lung_Disease::02_Asthma